{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:30:22Z","timestamp":1787988622524,"version":"build-2784847793"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210559","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T18:25:46Z","timestamp":1550082346000},"page":"e0210559","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5296-4264","authenticated-orcid":true,"given":"Amin S.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalton M.","family":"Mwaringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara A.","family":"Agutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy K.","family":"Ndirangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Mbisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-849X","authenticated-orcid":true,"given":"James A.","family":"Berkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"9849","key":"ref1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"R.K. Gupta","year":"2012","journal-title":"Lancet"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Q.D. Pham","year":"2014","journal-title":"Aids"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"R.L. Hamers","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European <italic>multicohort study<\/italic>","volume":"11","author":"L. Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel","volume":"312","author":"H.F. Gunthard","year":"2014","journal-title":"JAMA"},{"key":"ref6","unstructured":"World Health Organization global strategy for the surveillance and monitroing of HIV drug resistance: an update. 2012; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/77349\/1\/9789241504768_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/77349\/1\/9789241504768_eng.pdf<\/ext-link>."},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/JCM.37.7.2291-2296.1999","article-title":"Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase","volume":"37","author":"R. Schuurman","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"S. Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/cit125","article-title":"Clinical implications of HIV-1 minority variants","volume":"56","author":"J.Z. Li","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"e36494","DOI":"10.1371\/journal.pone.0036494","article-title":"Low-cost ultra-wide genotyping using Roche\/454 pyrosequencing for surveillance of HIV drug resistance","volume":"7","author":"D.M. Dudley","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nmeth995","article-title":"Detection of minor drug-resistant populations by parallel allele-specific sequencing","volume":"4","author":"F. Cai","year":"2007","journal-title":"Nat Methods"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/JCM.00431-07","article-title":"Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies","volume":"45","author":"M.S. Lalonde","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"B.B. Simen","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3851\/IMP1687","article-title":"HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis","volume":"16","author":"A.J. Buckton","year":"2011","journal-title":"Antivir Ther"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis","volume":"305","author":"J.Z. Li","year":"2011","journal-title":"Jama"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0b013e32834e9d7d","article-title":"Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure","volume":"26","author":"J.Z. Li","year":"2012","journal-title":"Aids"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":"Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated","volume":"192","author":"J.A. Johnson","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"e20357","DOI":"10.1371\/journal.pone.0020357","article-title":"Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis","volume":"6","author":"A. Hauser","year":"2011","journal-title":"PLoS One"},{"issue":"22","key":"ref19","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1105688108","article-title":"Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine","volume":"108","author":"V.F. Boltz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"e1001236","DOI":"10.1371\/journal.pmed.1001236","article-title":"Nevirapine- versus lopinavir\/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial","volume":"9","author":"S. Lockman","year":"2012","journal-title":"PLoS Med"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000312","article-title":"Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya","volume":"67","author":"M.H. Chung","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"D.E. Bennett","year":"2009","journal-title":"PLoS One"},{"key":"ref23","unstructured":"Guidelines for antiretroviral therapy in Kenya. 2011; 4th edition:[Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/healthservices.uonbi.ac.ke\/sites\/default\/files\/centraladmin\/healthservices\/Kenya%20Treatment%20Guidelines%202011.pdf\" xlink:type=\"simple\">http:\/\/healthservices.uonbi.ac.ke\/sites\/default\/files\/centraladmin\/healthservices\/Kenya%20Treatment%20Guidelines%202011.pdf<\/ext-link>."},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/aid.2011.0048","article-title":"HIV type 1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination","volume":"28","author":"S. Hue","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-60761-817-1_8","article-title":"HIV drug resistance testing","volume":"665","author":"P. Cane","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkw404","article-title":"Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK","volume":"72","author":"E. Cunningham","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"A.C. Pineda-Pena","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"19","key":"ref28","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/bioinformatics\/btq429","article-title":"Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology","volume":"26","author":"W. Delport","year":"2010","journal-title":"Bioinformatics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2105-7-265","article-title":"A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes","volume":"7","author":"A.K. Schultz","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"T.F. Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref31","unstructured":"Major HIV-1 Drug Resistance Mutations; Updated March 9, 2015. 24th July 2015]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/hivdb.stanford.edu\/pages\/download\/resistanceMutations_handout.pdf\" xlink:type=\"simple\">http:\/\/hivdb.stanford.edu\/pages\/download\/resistanceMutations_handout.pdf<\/ext-link>."},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/aid.2012.0167","article-title":"Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya","volume":"29","author":"A.S. Hassan","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiq167","article-title":"Differential persistence of transmitted HIV-1 drug resistance mutation classes","volume":"203","author":"V. Jain","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/infdis\/jit345","article-title":"Persistence of HIV-1 transmitted drug resistance mutations","volume":"208","author":"H. Castro","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-11-9","article-title":"HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study","volume":"11","author":"A.S. Hassan","year":"2014","journal-title":"AIDS Res Ther"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Cunningham, E., et al., Enhanced Surveillance of HIV-1 Transmitted Drug Resistance in Recently Infected MSM in the UK. (Submitted), 2015.","DOI":"10.1093\/jac\/dkw404"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"e98740","DOI":"10.1371\/journal.pone.0098740","article-title":"Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naive subjects in Hunan Province, China","volume":"9","author":"Z. Xiaobai","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0b013e3283427dcb","article-title":"Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy","volume":"25","author":"D.D. Goodman","year":"2011","journal-title":"AIDS"},{"key":"ref39","article-title":"Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis","author":"T.S. Boender","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"e86771","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure","volume":"9","author":"M.A. Vandenhende","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS","volume":"15","author":"D.R. Bangsberg","year":"2001","journal-title":"AIDS"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/01.aids.0000180094.04652.3b","article-title":"No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa","volume":"19","author":"C.J. Gill","year":"2005","journal-title":"AIDS"},{"key":"ref43","unstructured":"World Health Organization. Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV for HIV. September 2015 26th March 2015]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf<\/ext-link>."},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.aids.0000131391.91468.ff","article-title":"Persistence of primary drug resistance among recently HIV-1 infected adults","volume":"18","author":"J.D. Barbour","year":"2004","journal-title":"AIDS"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2144\/000113733","article-title":"Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications","volume":"51","author":"I. Vandenbroucke","year":"2011","journal-title":"Biotechniques"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T18:11:24Z","timestamp":1606500684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210559"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210559","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]}}}